Can EGFR lung cancer be cured?

Can EGFR lung cancer be cured?

Lung cancer is treatable. The outlook for people with EGFR lung cancer is improving with the use of targeted therapies. However, while EGFR inhibitors can control cancer progression for months or years, it’s not a cure.

How does EGFR mutation cause lung cancer?

EGFR’s job is to help cells grow and divide. In the case of EGFR-positive non small cell lung cancer (NSCLC), a mutation, or damage, in a gene causes the EGFR to remain stuck in the “on” position. This “drives” abnormal cell growth, which is what cancer is.

Does EGF cause cancer?

Mutations in EGF R have since been associated with a number of different cancers including non-small cell lung cancer, breast cancer, metastatic colorectal cancer and glioblastoma. Activation of EGF R leads to increased cell proliferation and cell growth and decreased programmed cell death (apoptosis).

Is EGFR lung cancer aggressive?

While the EGFR gene is most often associated with adenocarcinomas, some types of squamous cell carcinoma are affected by the protein as well. In these cancers, growth isn’t related to a mutation but to EGFR amplification, which causes rapid growth and results in highly aggressive tumors.

What is the best treatment for EGFR positive lung cancer?

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are the first-line treatment of choice for patients with EGFR mutation-positive non-small-cell lung cancer (NSCLC).

How do you test for EGFR mutation in lung cancer?

For diagnosis of your tumor, you will need a conventional tissue biopsy. In addition, blood tests for circulating tumor DNA (ctDNA), also called liquid biopsies, may be done to detect EGFR mutations in the tumor that can predict potential responsiveness or resistance to targeted therapies.

What is EGFR positive lung cancer?

EGFR positive lung cancer refers to lung cancers that test positive for an EGFR mutation. Lung cancers that are positive for EGFR mutations are mostly found in people with lung adenocarcinoma (a form of non-small cell lung cancer) and are more common in women than in men.

What does epidermal growth factor do?

A protein made by many cells in the body and by some types of tumors. It causes cells to grow and differentiate (become more specialized). It is a type of growth factor and a type of cytokine.

What does the epidermal growth factor receptor do?

The epidermal growth factor family of receptor tyrosine kinases (ErbBs) plays essential roles in regulating cell proliferation, survival, differentiation and migration. The ErbB receptors carry out both redundant and restricted functions in mammalian development and in the maintenance of tissues in the adult mammal.

What is the prognosis of epidermal growth factor receptor (EGF) mutations?

Mutations in epidermal growth factor receptor have been discovered in association with some lung cancers. Lung adenocarcinomas with mutated epidermal growth factor receptor have significant responses to tyrosine kinase inhibitors, although for unselected patients it does not appear to have a survival benefit.

Why is EGFR so important in non-small-cell lung cancer?

Advanced non-small-cell lung cancer (NSCLC) is the leading cause of cancer-related deaths in the world. Epidermal growth factor receptor (EGFR) is expressed in 50% of NSCLCs, and its expression is correlated with poor prognosis. These two factors make EGFR and its family members prime candidates for the development of targeted therapeutics.

What do we know about EGF receptor mutations in lung cancer?

Mulloy, R. et al. EGF receptor mutants from human lung cancers exhibit enhanced catalytic activity and increased sensitivity to gefitinib. Cancer Res. (in the press). Fabian, M. A. et al. A small molecule-kinase interaction map for clinical kinase inhibitors. Nature Biotechnol. 23, 329–336 (2005).

What is the function of epidermal growth factor receptor?

Abstract Epidermal growth factor receptor is a trans-membrane glycoprotein with an extracellular epidermal growth factor binding domain and an intracellular tyrosine kinase domain that regulates signaling pathways to control cellular proliferation.